CD8A and neoplasm: Despite these differences, we demonstrated that when compared to 21% O2 cultured control cells, mouse and human CD8+ T cells cultured in 1% O2 during T cell activation respectively display reduced B16-OVA tumour burdens, and extend survival of SKOV3 tumour-bearing animals.